0000899243-20-010341.txt : 20200406 0000899243-20-010341.hdr.sgml : 20200406 20200406193459 ACCESSION NUMBER: 0000899243-20-010341 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200403 FILED AS OF DATE: 20200406 DATE AS OF CHANGE: 20200406 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BARTHELEMY NICOLAS CENTRAL INDEX KEY: 0001283576 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-14656 FILM NUMBER: 20778107 MAIL ADDRESS: STREET 1: 1750 BELLA LAGUNA CT CITY: ENCINITAS STATE: CA ZIP: 92024 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REPLIGEN CORP CENTRAL INDEX KEY: 0000730272 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 042729386 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 41 SEYON STREET STREET 2: BUILDING 1, SUITE 100 CITY: WALTHAM STATE: MA ZIP: 02453 BUSINESS PHONE: 7814499560 MAIL ADDRESS: STREET 1: 41 SEYON STREET STREET 2: BUILDING 1, SUITE 100 CITY: WALTHAM STATE: MA ZIP: 02453 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-04-03 0 0000730272 REPLIGEN CORP RGEN 0001283576 BARTHELEMY NICOLAS C/O REPLIGEN CORPORATION 41 SEYON ST., BLDG 1, STE 100 WALTHAM MA 02453 1 0 0 0 Common Stock 2020-04-03 4 M 0 1652 42.07 A 6761 D Common Stock 2020-04-03 4 S 0 2688 99.99 D 4073 D Stock Option (Right to Buy) 42.07 2020-04-03 4 M 0 1652 0.00 D 2028-05-16 Common Stock 1652 1652 D Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on February 28, 2020. This option is currently exercisable. /s/ Jeffrey P. Leduc (Attorney in Fact) 2020-04-06